logo

For the Inventor, By the Inventor

Raleigh, NC, United States of America

Lilia M Beauchamp

This inventor holds 10 USPTO granted patents and 1 EPO patent. Top assignees: Burroughs Wellcome Co., Krenitsky Pharmaceuticals, Inc.. Active years: 1987-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lilia M Beauchamp. Retrieved from https://idiyas.com/inventor/lilia-m-beauchamp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 100.0


Average Co-Inventor Count = 1.5

ph-index = 6

Forward Citations = 284(Granted Patents)


Company Filing History:

goldMedal6 out of 521 
 
Burroughs Wellcome Co.
 patents
silverMedal4 out of 5 
 
Krenitsky Pharmaceuticals, Inc.
 patents

Years Active: 1987-2007

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 7205297 - Substituted 5-alkynyl pyrimidines having neurotrophic activity (2007-04-17),
2. 6916820 - Neurotrophic substituted pyrimidines (2005-07-12),
3. 6583148 - Neurotrophic substituted pyrimidines (2003-06-24),
4. 6440965 - Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system (2002-08-27),
5. 5318974 - Antiviral compounds (1994-06-07),
6. 5079252 - Therapeutic compounds (1992-01-07),
7. 5059604 - 2-amino purine derivatives (1991-10-22),
8. 5043339 - Antiviral compounds (1991-08-27),
9. 4957924 - Therapeutic valine esters of acyclovir and pharmaceutically acceptable (1990-09-18),
10. 4714701 - Antiviral compounds (1987-12-22),

Title: Lilia M Beauchamp: Innovator in Neuropharmaceuticals

Introduction

Lilia M Beauchamp is a prominent inventor based in Raleigh, NC (US). She has made significant contributions to the field of neuropharmaceuticals, holding a total of 10 patents. Her work focuses on developing novel compounds that have therapeutic potential for neurological disorders.

Latest Patents

Among her latest patents is a series of substituted 5-alkynyl pyrimidines that exhibit neurotrophic activity. This invention relates to pharmaceutical compositions containing these compounds, methods for their preparation, and their application in treating neurodegenerative disorders. These include age-related cognitive disorders such as senility and Alzheimer's disease, as well as nerve injuries and seizure disorders like epilepsy. Another notable patent involves neurotrophic substituted pyrimidines, which also target similar neurological conditions.

Career Highlights

Lilia has worked with reputable companies such as Burroughs Wellcome Co. and Krenitsky Pharmaceuticals, Inc. Her experience in these organizations has allowed her to advance her research and contribute to the development of innovative therapies.

Collaborations

Throughout her career, Lilia has collaborated with esteemed colleagues, including Thomas A Krenitsky and James L Kelley. These partnerships have played a crucial role in her research endeavors and patent developments.

Conclusion

Lilia M Beauchamp's work in neuropharmaceuticals highlights her dedication to addressing critical neurological disorders through innovative inventions. Her contributions continue to impact the field significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…